Enanta Pharmaceuticals (ENTA) Net Income Growth (1y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -115.33% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -73.01% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | 42.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.19% |
| Dec 31, 2025 | 46.44% |
| Sep 30, 2025 | 34.68% |
| Jun 30, 2025 | 19.43% |
| Mar 31, 2025 | 27.32% |
| Dec 31, 2024 | 33.28% |
| Sep 30, 2024 | -1.86% |
| Jun 30, 2024 | 42.00% |
| Mar 31, 2024 | 17.26% |
| Dec 31, 2023 | -15.25% |
| Sep 30, 2023 | -6.68% |
| Jun 30, 2023 | -23.23% |
| Mar 31, 2023 | -12.10% |
| Dec 31, 2022 | 3.75% |
| Sep 30, 2022 | 67.83% |
| Jun 30, 2022 | -31.95% |
| Mar 31, 2022 | 7.37% |
| Dec 31, 2021 | -261.61% |
| Sep 30, 2021 | -179.14% |
| Jun 30, 2021 | -68.41% |
| Mar 31, 2021 | -503.91% |
| Dec 31, 2020 | -161.95% |
| Sep 30, 2020 | -419.24% |
| Jun 30, 2020 | -302.74% |
| Mar 31, 2020 | -244.87% |
| Dec 31, 2019 | -48.32% |
| Sep 30, 2019 | -66.48% |
| Jun 30, 2019 | -65.32% |
| Mar 31, 2019 | -66.99% |
| Dec 31, 2018 | 122.45% |
| Sep 30, 2018 | -62.64% |
| Jun 30, 2018 | 221.98% |
| Mar 31, 2018 | 200.26% |
| Dec 31, 2017 | 245.00% |
| Sep 30, 2017 | 2,225.13% |
| Jun 30, 2017 | -7,896.15% |
| Mar 31, 2017 | -958.26% |
| Dec 31, 2016 | -117.66% |
| Sep 30, 2016 | -235.24% |
| Jun 30, 2016 | -113.32% |
| Mar 31, 2016 | -97.88% |
| Dec 31, 2015 | -53.89% |
| Sep 30, 2015 | 149.71% |
| Jun 30, 2015 | -92.11% |
| Mar 31, 2015 | 1,422.10% |
| Dec 31, 2014 | 1,943.82% |
| Sep 30, 2014 | -15.64% |
| Jun 30, 2014 | 578.71% |
| Mar 31, 2014 | -31.29% |
| Dec 31, 2013 | -124.48% |
| Sep 30, 2013 | -9.57% |
| Jun 30, 2013 | -18.91% |
| Mar 31, 2013 | -112.34% |